Phlow

Today, our CEO and Co-founder, Eric Edwards, MD, PhD, will participate in a panel discussion at the 2024 Zensights LLC Leadership Summit in Washington, D.C. This event brings together many of our nation's top military and government personnel alongside executives from America's biopharma industry to discuss strategies and principles for building high-performing teams. Eric Edwards, MD, PhD will be joined by co-panelists Jay Galeota, President and CEO of Kallyope, Inc.; Cari Almo Gallman, Executive Vice President of Corporate Affairs at Bristol Myers Squibb; and Bret Paulson, Vice President and Head of Market Access & Patient Experience at Otsuka Pharmaceutical Companies (U.S.); moderated by Bob Jansen, CEO of Zensights LLC.

We are thrilled to be adding to our Phlow team in Petersburg, VA. At Phlow, our dedication to excellence and innovation drives everything we do. As a Pharmaceutical Quality Specialist, you will be instrumental in upholding our unwavering commitment to quality and compliance. Click to learn more about this position: https://lnkd.in/eycrV2wK Required Qualifications: - Bachelor’s or Master’s degree in Science, Engineering, Pharmacy, or a related field.  - Minimum of 5-7 years of experience in a pharmaceutical or biotechnology environment.  - Strong knowledge of FDA, ICH and other global regulatory requirements, including cGMP and GAMP5. Tag someone or share this post to help us find the perfect candidate. #nowhiring #hiring #jobopening #jobposting #quality

Watch Now: Phlow’s Impact on Building Better Medicine! Join us in celebrating Phlow, a founding member of the Alliance, and its transformative role in modernizing medicine manufacturing in America and leading the way to a more sustainable and resilient future. Phlow is a U.S.-based, public benefit corporation that develops and domestically manufactures APIs and finished pharmaceutical products critical to the nation’s healthcare. Focused on impact, Phlow has state-of-the-art facilities in both Richmond and Petersburg. As a key collaborator within the Alliance, Phlow is locking arms with our other purpose-driven members to create a future where everyone has access to affordable, high-quality life-changing medicines. “It's been an honor and a privilege to be able to have this coalition of groups, whether they're economic development groups, service organizations, community colleges, and other universities, as well as other public and private companies coming together through a common cause to solve this critical, national public health security issue,” says Eric Edwards, MD, PhD, CEO and Co-Founder of Phlow. “What's happening in Petersburg is one of the most exciting things happening in the Commonwealth of Virginia,” adds Robby Demeria, Chief of Staff at Phlow and Founding Board Chair of the Alliance for Building Better Medicine. “We have manufacturing and high-paying jobs coming back to the region. Over $500 million in federal grants have been applied to the area, and close to a billion dollars when you factor in private investment, public investment, federal and state investment. It's one of the most incredible opportunities that's happening right now, and it is solely related to the very unique collaboration between all these different entities in the Alliance for Building Better Medicine.” 📽️ Watch the full video here to learn more about Phlow and the ongoing work of all Alliance members in our region as we work together to define a new era in R&D, advanced pharmaceutical manufacturing, workforce development, and supply chain development: https://lnkd.in/exmVEkwf

Today, we honor America's bravest men and women who have answered the call to defend our Nation. We are grateful for our veterans, active-duty military personnel, and their families for their service and sacrifices for our country. A special thank you goes out to our colleagues within the Phlow family who have served and continue to serve in the U.S. Armed Forces.

Yesterday, Phlow had the honor of hosting several members of the Children's Hospital Coalition. Esteemed leaders from Boston Children's Hospital, Ann & Robert H. Lurie Children's Hospital of Chicago, Children's Hospital of The King's Daughters, Children's Hospital of Richmond at VCU, and Children's National Hospital visited Phlow, a founding member of the Children's Hospital Coalition, to tour Phlow's state-of-the-art active pharmaceutical ingredient process research and development and manufacturing facilities in Richmond and Petersburg, VA. To learn more about the Children's Hospital Coalition, an unprecedented coalition of best-in-class children's hospitals that aims to ensure the reliable and affordable supply of high-quality essential medicines and help prevent pediatric drug shortages, visit https://lnkd.in/dJ9fg5r

Phlow is excited to expand it's purpose-driven team at it's state-of-the-art manufacturing facilities in Petersburg, VA. We are currently seeking for a dedicated and collaborative individual to join us as a Supervisor, Operations. This full-time role is perfect for candidates who thrive in a team-oriented environment and are eager to make a significant impact. To learn more about this opportunity, please visit: https://lnkd.in/eipQY9EZ. Additionally, Phlow is seeking an experienced and motivated Maintenance Mechanic. Reporting to the Maintenance Engineer, the successful candidate will play a crucial role in ensuring Phlow's production equipment's safety, quality, and performance. We welcome applicants who are enthusiastic about hands-on equipment repairs and have a keen eye for identifying potential equipment issues and process enhancements. For more details on the Maintenance Mechanic position, please click here: https://lnkd.in/e_yVApAE.

Recently, our Joint Project Manager for CBRN Medical announced their interagency contract with Phlow on a manufacturing effort for active pharmaceutical ingredients used to develop medical countermeasures. Awarded in partnership with the Biomedical Advanced Research and Development Authority (BARDA), this contract supports the United States Department of Defense’s objective to expand the domestic industrial base and increase readiness. This partnership with the U.S. Department of Health and Human Services (HHS) highlights our shared commitment to providing layered defense against threats to the warfighter and our Nation. Read more: https://lnkd.in/g6BrZriS #JPEOCBRND #CBRN #Medical #PressRelease #Partnerships #SaveLives

Phlow is pleased to announce the following well-deserved promotions: Andrew J. Carpenter, Ph.D., to Chief Scientific Officer; Chris Rogers to Chief Commercial Officer; Samantha Brock to Vice President of Quality and Regulatory; Alexandra Palmer Fabling to Sr. Director of Marketing and Communications; and Eric Mayhew to Sr. Director of Supply Chain.   Each of these team members has made invaluable contributions as we continue to drive impact, innovation and build U.S. supply chain resiliency. Their hard work and dedication have been instrumental in our success, and we are immensely grateful for their efforts.   Join us in congratulating this group on their new roles! We’re proud to have them as part of the Phlow team.

Phlow looks forward to attending CPHI in Milan, Italy, from October 8th to 10th. Phlow's CEO and Co-Founder Eric Edwards, MD, PhD, and Simon Hickling, Vice President of CDMO Business Development, will attend to connect with industry leaders from across the globe.   Phlow's goal is to never stop finding new ways to conserve resources and push the industry toward a sustainable future. Our team looks forward to discussing how our cutting-edge R&D and manufacturing facilities in Virginia can leverage continuous flow chemistry and other advanced small molecule manufacturing techniques to benefit your organization. To schedule a meeting with our team or learn more, click here: https://lnkd.in/erYdMT6B. We can't wait to connect with you at the conference!

Phlow supports the introduction of the bipartisan Federal Acquisition Security Council (FASC) Improvement Act of 2024, a significant step toward safeguarding the integrity of our Nation’s supply chains and protecting U.S. national security. At Phlow, we are committed to reducing reliance on foreign sources for critical pharmaceutical ingredients and building a secure, self-reliant domestic supply chain. This important bill strengthens our collective efforts to ensure federal procurement dollars are directed in ways that enhance national security, economic stability, and the health of our Nation. "Phlow is pleased and energized by policymakers taking measured and meaningful steps to strengthen our supply chains and support the revitalization of our domestic industrial base. The bipartisan Federal Acquisition Security Council Improvement Act of 2024 represents a thoughtful approach to ensuring that federal dollars are spent in ways that protect our national security and economic resilience,” says Eric Edwards, MD, PhD, co-founder and CEO of Phlow. “We applaud the collaborative efforts of these China Select Committee members in addressing this critical issue and look forward to supporting solutions that enhance the security of the U.S. supply chain as we work toward achieving pharmaceutical sovereignty." Read more about supporting a stronger, more resilient supply chain here: https://lnkd.in/eZZAQWq3